🟢 Veraxa Biotech is trading 14.27% up today — isolated rebound without a clear catalyst

Veraxa Biotech is trading 14.27% up now at $1.54, rebounding after several consecutive declines.

• Shares fell from $1.95 on August 21, 2026, to $1.35 on August 31, 2026.
• No clear company-specific announcement dated September 1 or August 31 explains the rebound; coverage shows no significant recent news catalyst.
• The broader biotechnology sector is down, making this appear to be an isolated rebound rather than sector-led buying.